DJ
Therapeutic Areas
Longeveron Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Laromestrocel (Lomecel-B™) | Alzheimer’s Disease | Phase 2 |
Leadership Team at Longeveron
SH
Stephen H. Willard
Chief Executive Officer
TP
Than Powell
Interim Chief Executive Officer, Vice President and Chief Business Officer
SK
Sunjay Kaushal, MD, PhD
Key Opinion Leader (Featured in KOL Event)
RK
Ram Kumar Subramanyan, MD, PhD
Key Opinion Leader (Featured in KOL Event)